Santen Pharmaceutical
(OTC) SNPHY
Santen Pharmaceutical Financials at a Glance
Market Cap
$3.82B
Revenue (TTM)
¥295.63B
Net Income (TTM)
¥37.93B
EPS (TTM)
$0.75
P/E Ratio
15.85
Dividend
$0.12
Beta (Volatility)
0.29 (Low)
Dividend
$0.12
Beta (Volatility)
0.29 (Low)
Price
$11.75
Volume
1,080
Open
$12.09
Price
$11.75
Volume
1,080
Open
$12.09
Previous Close
$11.88
Daily Range
$11.75 - $12.51
52-Week Range
$9.22 - $12.68
Estimated Earnings Date
May 11, 2026
Dividend
$0.12
Beta (Volatility)
0.29 (Low)
Price
$11.75
Volume
1,080
Open
$12.09
Previous Close
$11.88
Daily Range
$11.75 - $12.51
52-Week Range
$9.22 - $12.68
Estimated Earnings Date
May 11, 2026
SNPHY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Santen Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
3,849
CEO
Takeshi Ito
Website
www.santen.co.jpHeadquarters
Osaka, 530-8552, JP
SNPHY Financials
Key Financial Metrics (TTM)
Gross Margin
55%
Operating Margin
16%
Net Income Margin
13%
Return on Equity
13%
Return on Capital
13%
Return on Assets
9%
Earnings Yield
6.31%
Dividend Yield
1.02%
Payout Ratio
33.84%
Stock Overview
Market Cap
$3.82B
Shares Outstanding
321.69M
Volume
1.08K
Avg. Volume
12.37K
Financials (TTM)
Gross Profit
¥170.68B
Operating Income
¥47.94B
EBITDA
¥67.41B
Operating Cash Flow
¥46.12B
Capital Expenditure
-¥7.26B
Free Cash Flow
¥38.87B
Cash & ST Invst.
¥81.23B
Total Debt
¥0.00
Santen Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
¥82.35B
+6.6%
Gross Profit
¥50.58B
+9.7%
Gross Margin
61.43%
N/A
Market Cap
$3.82B
N/A
Market Cap/Employee
$1.02M
N/A
Employees
3,744
N/A
Net Income
¥15.83B
+80.1%
EBITDA
¥22.02B
+19.1%
Quarterly Fundamentals
Net Cash
¥81.23B
+35.9%
Accounts Receivable
¥72.14B
+0.5%
Inventory
¥64.86B
+25.7%
Long Term Debt
¥0.00
N/A
Short Term Debt
¥0.00
-100.0%
Return on Assets
8.83%
N/A
Return on Invested Capital
13.49%
N/A
Free Cash Flow
¥19.72B
+9.8%
Operating Cash Flow
¥21.59B
+14.3%